Kuwata T - Search Results

1

Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19.

Kaku Y, Kuwata T, Zahid HM, Hashiguchi T, Noda T, Kuramoto N, Biswas S, Matsumoto K, Shimizu M, Kawanami Y, Shimura K, Onishi C, Muramoto Y, Suzuki T, Sasaki J, Nagasaki Y, Minami R, Motozono C, Toyoda M, Takahashi H, Kishi H, Fujii K, Tatsuke T, Ikeda T, Maeda Y, Ueno T, Koyanagi Y, Iwagoe H, Matsushita S. Kaku Y, et al. Among authors: kuwata t. Cell Rep. 2021 Jul 13;36(2):109385. doi: 10.1016/j.celrep.2021.109385. Epub 2021 Jun 25. Cell Rep. 2021. PMID: 34237284 Free PMC article.

2

Conformational epitope consisting of the V3 and V4 loops as a target for potent and broad neutralization of simian immunodeficiency viruses.

Kuwata T, Takaki K, Yoshimura K, Enomoto I, Wu F, Ourmanov I, Hirsch VM, Yokoyama M, Sato H, Matsushita S. Kuwata T, et al. J Virol. 2013 May;87(10):5424-36. doi: 10.1128/JVI.00201-13. Epub 2013 Mar 6. J Virol. 2013. PMID: 23468483 Free PMC article.

3

Increased infectivity in human cells and resistance to antibody-mediated neutralization by truncation of the SIV gp41 cytoplasmic tail.

Kuwata T, Kaori T, Enomoto I, Yoshimura K, Matsushita S. Kuwata T, et al. Front Microbiol. 2013 May 14;4:117. doi: 10.3389/fmicb.2013.00117. eCollection 2013. Front Microbiol. 2013. PMID: 23717307 Free PMC article.

4

Complementary and synergistic activities of anti-V3, CD4bs and CD4i antibodies derived from a single individual can cover a wide range of HIV-1 strains.

Ramirez Valdez KP, Kuwata T, Maruta Y, Tanaka K, Alam M, Yoshimura K, Matsushita S. Ramirez Valdez KP, et al. Among authors: kuwata t. Virology. 2015 Jan 15;475:187-203. doi: 10.1016/j.virol.2014.11.011. Epub 2014 Dec 5. Virology. 2015. PMID: 25486586 Free article.

5

Incompatible Natures of the HIV-1 Envelope in Resistance to the CCR5 Antagonist Cenicriviroc and to Neutralizing Antibodies.

Kuwata T, Enomoto I, Baba M, Matsushita S. Kuwata T, et al. Antimicrob Agents Chemother. 2015 Nov 2;60(1):437-50. doi: 10.1128/AAC.02285-15. Print 2016 Jan. Antimicrob Agents Chemother. 2015. PMID: 26525792 Free PMC article.

6

Cross-Neutralization Activity of Single-Chain Variable Fragment (scFv) Derived from Anti-V3 Monoclonal Antibodies Mediated by Post-Attachment Binding.

Maruta Y, Kuwata T, Tanaka K, Alam M, Valdez KP, Egami Y, Suwa Y, Morioka H, Matsushita S. Maruta Y, et al. Among authors: kuwata t. Jpn J Infect Dis. 2016 Sep 21;69(5):395-404. doi: 10.7883/yoken.JJID.2015.667. Epub 2016 Feb 19. Jpn J Infect Dis. 2016. PMID: 26902223 Free article.

7

Enhanced antibody-mediated neutralization of HIV-1 variants that are resistant to fusion inhibitors.

Alam M, Kuwata T, Shimura K, Yokoyama M, Ramirez Valdez KP, Tanaka K, Maruta Y, Oishi S, Fujii N, Sato H, Matsuoka M, Matsushita S. Alam M, et al. Among authors: kuwata t. Retrovirology. 2016 Sep 27;13(1):70. doi: 10.1186/s12977-016-0304-7. Retrovirology. 2016. PMID: 27670680 Free PMC article.

8

Unique binding modes for the broad neutralizing activity of single-chain variable fragments (scFv) targeting CD4-induced epitopes.

Tanaka K, Kuwata T, Alam M, Kaplan G, Takahama S, Valdez KPR, Roitburd-Berman A, Gershoni JM, Matsushita S. Tanaka K, et al. Among authors: kuwata t. Retrovirology. 2017 Sep 22;14(1):44. doi: 10.1186/s12977-017-0369-y. Retrovirology. 2017. PMID: 28938888 Free PMC article.

9

Total HIV-1 DNA Dynamics and Influencing Factors in Long-Term ART-Treated Japanese Adults: A Retrospective Longitudinal Analysis.

Stanoeva KR, König A, Fukuda A, Kawanami Y, Kuwata T, Satou Y, Matsushita S. Stanoeva KR, et al. Among authors: kuwata t. J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):239-247. doi: 10.1097/QAI.0000000000001662. J Acquir Immune Defic Syndr. 2018. PMID: 29481485

10

The role of conventional antibodies targeting the CD4 binding site and CD4-induced epitopes in the control of HIV-1 CRF01_AE viruses.

Thida W, Kuwata T, Maeda Y, Yamashiro T, Tran GV, Nguyen KV, Takiguchi M, Gatanaga H, Tanaka K, Matsushita S. Thida W, et al. Among authors: kuwata t. Biochem Biophys Res Commun. 2019 Jan 1;508(1):46-51. doi: 10.1016/j.bbrc.2018.11.063. Epub 2018 Nov 20. Biochem Biophys Res Commun. 2019. PMID: 30470571

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

634 results

Search Page

Filters